smscall
logo
Pharma & Healthcare

Published On: May 17, 2025

Global Methotrexate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 198 Pages
  • 0 Views

Version Type

$3,950.00

Summary
According to APO Research, The global Methotrexate Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Methotrexate Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Methotrexate Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Methotrexate Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Methotrexate Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Methotrexate Injection include Accord, Get Well Pharmaceutical, Hikma, Fresenius Kabi, Guangdong Lingnan Pharma, Hengrui Medicine, Pfizer, Mylan and Qilu Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Methotrexate Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Methotrexate Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Methotrexate Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methotrexate Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Methotrexate Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Methotrexate Injection sales, projected growth trends, production technology, application and end-user industry.
Methotrexate Injection Segment by Company
Accord
Get Well Pharmaceutical
Hikma
Fresenius Kabi
Guangdong Lingnan Pharma
Hengrui Medicine
Pfizer
Mylan
Qilu Pharmaceutical
Shanxi Pude Pharma
Sichuan Huiyu Pharma
Teva
Youcare Pharmaceutical Group
Methotrexate Injection Segment by Type
Preservative-Free
With Preservative
Methotrexate Injection Segment by Application
Specialty Clinic
Hospital
Recovry Center
Methotrexate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Methotrexate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Methotrexate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Methotrexate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Table 1:Methotrexate Injection Industry Trends
Table 2:Methotrexate Injection Industry Drivers
Table 3:Methotrexate Injection Industry Opportunities and Challenges
Table 4:Methotrexate Injection Industry Restraints
Table 5:Global Methotrexate Injection Revenue by Manufacturers (US$ Million) & (2020-2025)
Table 6:Global Methotrexate Injection Revenue Market Share by Manufacturers (2020-2025)
Table 7:Global Methotrexate Injection Sales by Manufacturers (W Units) & (2020-2025)
Table 8:Global Methotrexate Injection Sales Market Share by Manufacturers
Table 9:Global Methotrexate Injection Average Sales Price (US$/Unit) of Manufacturers (2020-2025)
Table 10:Global Methotrexate Injection Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
Table 11:Global Methotrexate Injection Key Manufacturers Manufacturing Sites & Headquarters
Table 12:Global Methotrexate Injection Manufacturers, Product Type & Application
Table 13:Global Methotrexate Injection Manufacturers Establishment Date
Table 14:Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15:Global Methotrexate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2024)
Table 16:Major Manufacturers of Preservative-Free
Table 17:Major Manufacturers of With Preservative
Table 18:Global Methotrexate Injection Sales by Type 2020 VS 2024 VS 2031 (W Units)
Table 19:Global Methotrexate Injection Sales by Type (2020-2025) & (W Units)
Table 20:Global Methotrexate Injection Sales by Type (2026-2031) & (W Units)
Table 21:Global Methotrexate Injection Sales Market Share by Type (2020-2025)
Table 22:Global Methotrexate Injection Sales Market Share by Type (2026-2031)
Table 23:Global Methotrexate Injection Revenue by Type 2020 VS 2024 VS 2031 (W Units)
Table 24:Global Methotrexate Injection Revenue by Type (2020-2025) & (W Units)
Table 25:Global Methotrexate Injection Revenue by Type (2026-2031) & (W Units)
Table 26:Global Methotrexate Injection Revenue Market Share by Type (2020-2025)
Table 27:Global Methotrexate Injection Revenue Market Share by Type (2026-2031)
Table 28:Major Manufacturers of Specialty Clinic
Table 29:Major Manufacturers of Hospital
Table 30:Major Manufacturers of Recovry Center
Table 31:Global Methotrexate Injection Sales by Application 2020 VS 2024 VS 2031 (W Units)
Table 32:Global Methotrexate Injection Sales by Application (2020-2025) & (W Units)
Table 33:Global Methotrexate Injection Sales by Application (2026-2031) & (W Units)
Table 34:Global Methotrexate Injection Sales Market Share by Application (2020-2025)
Table 35:Global Methotrexate Injection Sales Market Share by Application (2026-2031)
Table 36:Global Methotrexate Injection Revenue by Application 2020 VS 2024 VS 2031 (W Units)
Table 37:Global Methotrexate Injection Revenue by Application (2020-2025) & (W Units)
Table 38:Global Methotrexate Injection Revenue by Application (2026-2031) & (W Units)
Table 39:Global Methotrexate Injection Revenue Market Share by Application (2020-2025)
Table 40:Global Methotrexate Injection Revenue Market Share by Application (2026-2031)
Table 41:Global Methotrexate Injection Sales by Region: 2020 VS 2024 VS 2031 (W Units)
Table 42:Global Methotrexate Injection Sales by Region (2020-2025) & (W Units)
Table 43:Global Methotrexate Injection Sales Market Share by Region (2020-2025)
Table 44:Global Methotrexate Injection Sales Forecasted by Region (2026-2031) & (W Units)
Table 45:Global Methotrexate Injection Sales Forecasted Market Share by Region (2026-2031)
Table 46:North America Methotrexate Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units)
Table 47:North America Methotrexate Injection Sales by Country (2020-2025) & (W Units)
Table 48:North America Methotrexate Injection Sales by Country (2026-2031) & (W Units)
Table 49:Europe Methotrexate Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units)
Table 50:Europe Methotrexate Injection Sales by Country (2020-2025) & (W Units)
Table 51:Europe Methotrexate Injection Sales by Country (2026-2031) & (W Units)
Table 52:Asia Pacific Methotrexate Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units)
Table 53:Asia Pacific Methotrexate Injection Sales by Country (2020-2025) & (W Units)
Table 54:Asia Pacific Methotrexate Injection Sales by Country (2026-2031) & (W Units)
Table 55:South America, Middle East and Africa Methotrexate Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units)
Table 56:South America, Middle East and Africa Methotrexate Injection Sales by Country (2020-2025) & (W Units)
Table 57:South America, Middle East and Africa Methotrexate Injection Sales by Country (2026-2031) & (W Units)
Table 58:Global Methotrexate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 59:Global Methotrexate Injection Revenue by Region (2020-2025) & (US$ Million)
Table 60:Global Methotrexate Injection Revenue by Region (2026-2031) & (US$ Million)
Table 61:Global Methotrexate Injection Revenue Market Share by Region (2020-2025)
Table 62:Global Methotrexate Injection Revenue Market Share by Region (2026-2031)
Table 63:Accord Company Information
Table 64:Accord Business Overview
Table 65:Accord Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 66:Accord Methotrexate Injection Product Portfolio
Table 67:Accord Recent Development
Table 68:Get Well Pharmaceutical Company Information
Table 69:Get Well Pharmaceutical Business Overview
Table 70:Get Well Pharmaceutical Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71:Get Well Pharmaceutical Methotrexate Injection Product Portfolio
Table 72:Get Well Pharmaceutical Recent Development
Table 73:Hikma Company Information
Table 74:Hikma Business Overview
Table 75:Hikma Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 76:Hikma Methotrexate Injection Product Portfolio
Table 77:Hikma Recent Development
Table 78:Fresenius Kabi Company Information
Table 79:Fresenius Kabi Business Overview
Table 80:Fresenius Kabi Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 81:Fresenius Kabi Methotrexate Injection Product Portfolio
Table 82:Fresenius Kabi Recent Development
Table 83:Guangdong Lingnan Pharma Company Information
Table 84:Guangdong Lingnan Pharma Business Overview
Table 85:Guangdong Lingnan Pharma Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 86:Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
Table 87:Guangdong Lingnan Pharma Recent Development
Table 88:Hengrui Medicine Company Information
Table 89:Hengrui Medicine Business Overview
Table 90:Hengrui Medicine Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 91:Hengrui Medicine Methotrexate Injection Product Portfolio
Table 92:Hengrui Medicine Recent Development
Table 93:Pfizer Company Information
Table 94:Pfizer Business Overview
Table 95:Pfizer Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 96:Pfizer Methotrexate Injection Product Portfolio
Table 97:Pfizer Recent Development
Table 98:Mylan Company Information
Table 99:Mylan Business Overview
Table 100:Mylan Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 101:Mylan Methotrexate Injection Product Portfolio
Table 102:Mylan Recent Development
Table 103:Qilu Pharmaceutical Company Information
Table 104:Qilu Pharmaceutical Business Overview
Table 105:Qilu Pharmaceutical Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 106:Qilu Pharmaceutical Methotrexate Injection Product Portfolio
Table 107:Qilu Pharmaceutical Recent Development
Table 108:Shanxi Pude Pharma Company Information
Table 109:Shanxi Pude Pharma Business Overview
Table 110:Shanxi Pude Pharma Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111:Shanxi Pude Pharma Methotrexate Injection Product Portfolio
Table 112:Shanxi Pude Pharma Recent Development
Table 113:Sichuan Huiyu Pharma Company Information
Table 114:Sichuan Huiyu Pharma Business Overview
Table 115:Sichuan Huiyu Pharma Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 116:Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
Table 117:Sichuan Huiyu Pharma Recent Development
Table 118:Teva Company Information
Table 119:Teva Business Overview
Table 120:Teva Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 121:Teva Methotrexate Injection Product Portfolio
Table 122:Teva Recent Development
Table 123:Youcare Pharmaceutical Group Company Information
Table 124:Youcare Pharmaceutical Group Business Overview
Table 125:Youcare Pharmaceutical Group Methotrexate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 126:Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
Table 127:Youcare Pharmaceutical Group Recent Development
Table 128:Key Raw Materials
Table 129:Raw Materials Key Suppliers
Table 130:Methotrexate Injection Distributors List
Table 131:Methotrexate Injection Customers List
Table 132:Research Programs/Design for This Report
Table 133:Authors List of This Report
Table 134:Secondary Sources
Table 135:Primary Sources
Figure 1:Methotrexate Injection Product Image
Figure 2:Global Methotrexate Injection Market Size (US$ Million), 2020 VS 2024 VS 2031
Figure 3:Global Methotrexate Injection Market Size (2020-2031) & (US$ Million)
Figure 4:Global Methotrexate Injection Sales (2020-2031) & (W Units)
Figure 5:Global Methotrexate Injection Average Price (US$/Unit) & (2020-2031)
Figure 6:Global Top 5 and 10 Methotrexate Injection Players Market Share by Revenue in 2023
Figure 7:Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8:Preservative-Free Image
Figure 9:With Preservative Image
Figure 10:Global Methotrexate Injection Sales by Type (2020 VS 2024 VS 2031) & (W Units)
Figure 11:Global Methotrexate Injection Sales Market Share 2020 VS 2024 VS 2031
Figure 12:Global Methotrexate Injection Sales Market Share by Type (2020-2031)
Figure 13:Global Methotrexate Injection Revenue by Type (2020 VS 2024 VS 2031) & (W Units)
Figure 14:Global Methotrexate Injection Revenue Market Share 2020 VS 2024 VS 2031
Figure 15:Global Methotrexate Injection Revenue Market Share by Type (2020-2031)
Figure 16:Specialty Clinic Image
Figure 17:Hospital Image
Figure 18:Recovry Center Image
Figure 19:Global Methotrexate Injection Sales by Application (2020 VS 2024 VS 2031) & (W Units)
Figure 20:Global Methotrexate Injection Sales Market Share 2020 VS 2024 VS 2031
Figure 21:Global Methotrexate Injection Sales Market Share by Application (2020-2031)
Figure 22:Global Methotrexate Injection Revenue by Application (2020 VS 2024 VS 2031) & (W Units)
Figure 23:Global Methotrexate Injection Revenue Market Share 2020 VS 2024 VS 2031
Figure 24:Global Methotrexate Injection Revenue Market Share by Application (2020-2031)
Figure 25:North America Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 26:North America Methotrexate Injection Sales Market Share by Country (2020-2031)
Figure 27:U.S. Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 28:Canada Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 29:Mexico Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 30:Europe Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 31:Europe Methotrexate Injection Sales Market Share by Country (2020-2031)
Figure 32:Germany Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 33:France Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 34:U.K. Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 35:Italy Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 36:Netherlands Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 37:Asia Pacific Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 38:Asia Pacific Methotrexate Injection Sales Market Share by Country (2020-2031)
Figure 39:China Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 40:Japan Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 41:South Korea Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 42:Southeast Asia Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 43:India Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 44:Australia Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 45:South America, Middle East and Africa Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 46:South America, Middle East and Africa Methotrexate Injection Sales Market Share by Country (2020-2031)
Figure 47:Brazil Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 48:South Africa Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 49:Saudi Arabia Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 50:Turkey Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 51:Argentina Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 52:UAE Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 53:Egypt Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 54:Chile Methotrexate Injection Sales and Growth Rate (2020-2031) & (W Units)
Figure 55:Global Methotrexate Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 56:Global Methotrexate Injection Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 57:North America Methotrexate Injection Revenue (2020-2031) & (US$ Million)
Figure 58:North America Methotrexate Injection Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 59:Europe Methotrexate Injection Revenue (2020-2031) & (US$ Million)
Figure 60:Europe Methotrexate Injection Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 61:Asia-Pacific Methotrexate Injection Revenue (2020-2031) & (US$ Million)
Figure 62:Asia-Pacific Methotrexate Injection Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 63:South America, Middle East and Africa Methotrexate Injection Revenue (2020-2031) & (US$ Million)
Figure 64:South America, Middle East and Africa Methotrexate Injection Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 65:Methotrexate Injection Value Chain
Figure 66:Manufacturing Cost Structure
Figure 67:Methotrexate Injection Production Mode & Process
Figure 68:Direct Comparison with Distribution Share
Figure 69:Distributors Profiles
Figure 70:Years Considered
Figure 71:Research Process
Figure 72:Key Executives Interviewed

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Pharma & Healthcare

Global Methotrexate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

0| 0 Reviews

Pages: 198

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.